Camila Bragança Xavier

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial”.

Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial

Journal of Immunotherapy and Precision Oncology(2025)10.36401/jipo-24-27

N/A

0.179DataRank · unranked

2 citations

Camila Bragança Xavier, Bettzy Stephen, Jeffrey How, Justin T. Moyers, Vivek Subbiah +3 more

Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case series

npj Precision Oncology(2025)10.1038/s41698-025-01115-0

N/A

0DataRank · unranked

0 citations

Mohamed A. Gouda, Apostolia M. Tsimberidou, Camila Bragança Xavier

532 A phase 1 dose escalation and dose expansion trial of NP-101 in patients with advanced solid tumors

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0532

N/A

0DataRank · unranked

0 citations

Bettzy Stephen, Serdar A. Gurses, Michelle York Gocio, Mohamed Omar Kaseb, Yali Yang +18 more